Development and evaluation of Nurse Practitioner follow-up in the management of patients with lung cancer.

ISRCTN ISRCTN64726310
DOI https://doi.org/10.1186/ISRCTN64726310
Secondary identifying numbers NCP/J17/18
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
22/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jessica Corner
Scientific

The Institute of Cancer Research
The Centre for Cancer and Palliative Care Studies
Royal Cancer Hospital
Fulham Road
London
SW3 6JJ
United Kingdom

Phone +44 (0)20 7352 8171

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer (neoplasms): Lung (non-small cell)
Intervention1. Conventional medical follow-up:
At the specialist cancer hospital, patients were seen within one month and, if stable, discharged back to their referring cancer unit. At the cancer units, follow-up was 2 - 3 monthly if patients were stable. At all centres, patients who were not considered medically stable were seen on the basis of need.
2. Nurse-led follow-up:
Patients allocated to one of two Clinical Nurse Specialists (CNS) who took responsibility for their follow-up care for one year. Patients assessed monthly or on basis of need by telephone or at a nurse-led clinic. Patients could also use a paging system to contact CNS if they had concerns during intervals between assessments. Focus of care was not only disease surveillance but also the physical, psychological and social needs of patients and their families. Emphasis on prompt communication and liaison with primary care teams. Patients attended hospital medical clinics only if their condition indicated this was needed or if patients requested a consultation with a hospital physician.
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1999
Completion date01/01/2001

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Patients with lung cancer having completed initial treatment
2. Not requiring immediate medical intervention or close medical supervision
3. Considered to have a good performance status (World Health Organization [WHO] performance status 0 - 2)
4. Had an expected prognosis of at least 3 months
5. Were not participating in other clinical trials requiring intensive medical investigation or follow-up
6. Understood and read English for informed consent and data collection purposes
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/1999
Date of final enrolment01/01/2001

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

The Institute of Cancer Research
London
SW3 6JJ
United Kingdom

Sponsor information

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Cancer National Research and Development Programme (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 16/11/2002 Yes No